C3i names Song business development executive in Asia

Monday, July 16, 2012 10:57 AM

C3i, which provides service desk support and business process outsourcing (BPO) services for the life sciences industry, has appointed Jonathan Song business development executive in Asia.

C3i recently opened an operations center in Dalian, China to address the IT support needs of pharmaceutical companies doing business in the main Asian markets. Song will support C3i's strategy to expand its clinical and commercial solutions to pharmaceutical, biotechnology and clinical research organizations in Asia.

Song has 20 years of pharmaceutical and healthcare experience in China and the U.S., both in industry and agency, including positions at Merck and Sinopharm.

 

Share:          
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

December 17

Medici Global says its Alzheimer's Facebook page demonstrates the need for more early detection trials

Analysts: Expect more equity purchases of CROs in 2013

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

January 2013

Parexel celebrates 30 years of change, growth
CRO's founder and chairman reflects on challenges of the past, present and future

Strategies for increasing patient diversity in trials
Sponsors look to improve racial, ethnic recruitment without going overseas

Already a subscriber?
Log in to your digital subscription.

Purchase the January issue.

Subscribe to The CenterWatch Monthly.

December 2012

Publicity, regulation tightening reins on use of KOLs
Debate rages over need to revamp how sponsors use, pay medical experts

Time may be right to makeover the investigator brochure
Size, complexity prevent critical document from being thoroughly read

Already a subscriber?
Log in to your digital subscription.

Purchase the December issue.

Subscribe to The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs